After facing criticism from President Donald Trump, Pfizer is reversing course on recent drug price increases; HHS Secretary Alex Azar has become the point person for the migrant crisis, splitting his attention between reuniting families and healthcare issues like drug costs and the opioid epidemic; a Senate panel has voted to back Robert Wilkie to lead the Department of Veterans Affairs (VA).
After facing criticism from President Donald Trump, Pfizer is reversing course on some recent drug price increases. According to The Wall Street Journal, Pfizer decided to return drug prices to where they were before July 1 after its CEO had a long talk with Trump. The pause on price increases will remain until either the president puts into place his plan to curb drug prices or the end of the year.
Since the president implemented a zero-tolerance border policy, HHS Secretary Alex Azar has become the point person for the migrant crisis. As he’s been working to reunite the thousands of children separated from their parents, Azar is still trying to focus on healthcare issues like drug costs and the opioid epidemic, reported Politico. However, because HHS takes custody of refugees, Azar is in charge of addressing the situation, and it has pulled some time and resources away from other issues, said insiders.
The Senate Veterans Affairs Committee voted to back Robert Wilkie, the president’s pick to lead the Department of Veterans Affairs (VA). Senator Bernie Sanders, I-Vermont, was the only “no” vote on the committee, according to The Associated Press. The VA has been beset by turmoil over delays in providing care to veterans. Wilkie has insisted he would not seek to privatize the VA, something Trump is eager to do. If confirmed by the full Senate, Wilkie will be in charge of carrying out a new law from the president that would ease veterans’ access to private healthcare providers.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More